Stock INCR INTERCURE LTD.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

InterCure Ltd. Share Price TEL AVIV STOCK EXCHANGE

Equities

INCR

IL0011063760

Healthcare Facilities & Services

Financials

Sales 2021 219.68 836.31 17.59K Sales 2022 388.68 1.48K 31.12K Capitalization 551M 2.1B 44.07B
Net income 2021 4M 15.23M 320M Net income 2022 44M 168M 3.52B EV / Sales 2021 3,844,919 x
Net cash position 2021 87.64M 334M 7.02B Net Debt 2022 22.37M 85.15M 1.79B EV / Sales 2022 1,473,908 x
P/E ratio 2021
207 x
P/E ratio 2022
12.2 x
Employees -
Yield 2021 *
-
Yield 2022
-
Free-Float 64.2%
More Fundamentals * Assessed data

Chart InterCure Ltd.

Dynamic Chart

Latest news about InterCure Ltd.

InterCure Ltd. Provides Earnings Guidance for the Second Half and Full Year of 2023 CI
InterCure Ltd. Expects to Launch Its First Products in Germany in the Coming Months CI
InterCure Ltd. Announces Resignation of Rami Levy as Chief of Operations CI
InterCure Ltd. entered into a share purchase agreement to acquire Leon Pharm Ltd for ILS 8.3 million. CI
InterCure Ltd.(TASE:INCR) dropped from S&P Global BMI Index CI
InterCure Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Intercure to Delist Its Shares From the Toronto Stock Exchange MT
InterCure Provides Update About Lawsuit it Filed Against Cann Pharmaceuticals to Recover Funds Following Failed Merger MT
Transcript : InterCure Ltd., 2022 Earnings Call, Apr 04, 2023
InterCure Ltd. entered into an agreement to acquire 51% stake in Orni Pharmacy Ltd. CI
InterCure to Launch Trading on Nasdaq Wednesday MT
InterCure Ltd. Announces Earnings Results for the Second Quarter Ended June 30, 2021 CI
InterCure Provided Update on Its NASDAQ Listing MT
InterCure Ltd signed a Letter of Intent to acquire Cann Pharmaceutical Ltd. for $35 million. CI
InterCure : Israel's Canndoc signs cannabis import-export deal with Tilray RE
More news

Latest transcript on InterCure Ltd.

Logo InterCure Ltd.
InterCure Ltd., 2022 Earnings Call, Apr 04, 2023
More transcripts

Press releases InterCure Ltd.

InterCure : Preliminary results for the full year of 2023 PU
InterCure Announces Preliminary Estimated 2023 Revenue of NIS 351 million and EBITDA of over NIS 50 million BU
InterCure : Announces Preliminary Estimated 2023 Revenue of NIS 351 million and EBIDTA of over NIS 50 million - Form 6-K PU
InterCure Congratulates Germany on Cannabis Reform, Expanding its Global Footprint BU
InterCure Provides an Update Regarding Nir Oz Facility AQ
More press releases

News in other languages on InterCure Ltd.

Tilray, Inc. : première exportation de cannabis vers Israël
More news

Managers and Directors - InterCure Ltd.

Managers TitleAgeSince
Alexander Rabinovitch CEO
 Chief Executive Officer 53 30/09/18
Amos Cohen DFI
 Director of Finance/CFO 45 29/02/20
Boaz Lahav SAM
 Sales & Marketing - 31/10/22
Members of the board TitleAgeSince
Ehud Barak CHM
 Chairman 81 31/08/18
Alexander Rabinovitch CEO
 Chief Executive Officer 53 30/09/18
Alon Shmuel Granot BRD
 Director/Board Member 62 31/10/20
More insiders

Company Profile

InterCure Ltd is an Israel-based company primarily enagged in cannabis industry. Thorugh its wholly owned subsidiary Canndoc the Company operates as licensed cannabis producer and one of the first to offer Good Manufacturing Practices (GMP) certified and pharmaceutical-grade medical cannabis products.
Sector
Healthcare Facilities & Services
Calendar
12/05/2024 - Q1 2024 Earnings Release (Projected)
More about the company

Sector Medical Farming

1st Jan change Capi.
ASCEND WELLNESS HOLDINGS, INC. Stock Ascend Wellness Holdings, Inc.
+31.96% 272M
AYR WELLNESS INC. Stock Ayr Wellness Inc.
+33.74% 261M
ORGANIGRAM HOLDINGS INC. Stock Organigram Holdings Inc.
+49.42% 194M
JUSHI HOLDINGS INC. Stock Jushi Holdings Inc.
+44.98% 131M
IANTHUS CAPITAL HOLDINGS, INC. Stock iAnthus Capital Holdings, Inc.
-28.57% 121M
4FRONT VENTURES CORP. Stock 4Front Ventures Corp.
0.00% 86.82M
BAKHU HOLDINGS, CORP. Stock Bakhu Holdings, Corp.
+150.00% 75.33M
CANNARA BIOTECH INC. Stock Cannara Biotech Inc.
+1.20% 55.24M
GOLD FLORA CORPORATION Stock Gold Flora Corporation
+14.38% 52.63M
Medical Farming
  1. Stock Market
  2. Equities
  3. INCR Stock
  4. INCR Stock